John A. Williams
  Chairman and CEO

A seasoned businessman and entrepreneur, John has led BioSignia since 2006. He is the co-founder of several banks, including Unity Bank and First Carolina State Bank, where he served as Chairman of the Board. In addition to his work in commercial and residential land development, he was elected Edgecombe County Commissioner. John attended the Electronic Computer Programming Institute, the University of Georgia and the University of Michigan.

Gregory Rossi, CPA
  Executive Vice President, Finance and Administration

Greg is BioSignia’s senior financial executive. Before joining us, he served as Corporate Controller at SpecComm International, a magazine publisher, and Corporate Accounting Manager at CardSmart Retail. Greg holds a B.A. in Accounting from North Carolina State University.

Randall Bowen
 Executive Vice President/ Director of Operations

Randall currently serves as the head of Operations for BioSignia and is a seasoned executive with over 15 years of experience in healthcare, insurance, and financial services industries. Prior to this role, he was VP Global Customer Experience for Genworth Financial, a leading global financial security company with a presence in more than 25 countries. Earlier, he oversaw Six Sigma quality initiatives for the Marketing and Product Management group of GE Financial Assurance, Genworth’s predecessor company. Previously, Randall held a succession of brand, marketing, and corporate communications roles at GE Capital. He began his career in hospital administration in Southern California. Randall is a certified Six Sigma Master Black Belt, a graduate of Dawson College and has completed graduate school at The University of Leicester School of Management.

Guizhou Hu, M.D., Ph.D.
  Senior Vice President and Chief Scientific Officer

Guizhou leads BioSignia's R & D team. He is the primary inventor on the patent of our Synthesis Analysis technology and has spearheaded the development of its proprietary applications. He has been hailed as "one of the brightest young minds" by the Chinese Academy of Preventive Medicine. Guizhou earned his M.D. at Beijing Medical University. He also holds both an M.S. in nutritional toxicology and a Ph.D. in epidemiology from Cornell University. Giuzhou joined BioSignia in 1998.

Jack Smith
  Executive Vice President - Business Development

Jack recently joined BioSignia from Life Line Screening. As Senior V. P. of Business Development at LLS, he managed all client relationships with insurance carriers. Jack previously served as Senior V.P. of Business Development and Divisional V.P. of Sales at the Long Term Care Company of G.E. Financial. Jack has also held senior sales management positions at CITC Industries, Brown Group and Nike.

Ashlee Duncan, Ph.D.
  Senior Scientist/Epidemiologist

As a senior member of our R & D team, Ashlee tests and evaluates BioSignia's proprietary technologies and applications. Prior to joining us, she was an epidemiologist in the Drug Development Sciences division of GlaxoSmithKline. She has also worked at the EPA and NIH. Ashlee received an M.S. in toxicology and a Ph.D. in epidemiology from North Carolina State University.

 John L. Schilhab
 Senior V.P. Know Your Number®

A business development professional with over 25 years of experience in the financial services industry, John has an impressive track record of key account acquisition and relationship management. He most recently held senior Business Development and Sales Management positions with The Kessler Group and with GE/Genworth Financial. John is a graduate of The University of Houston with a BSBA degree.

Andy Effenson
 V.P. Business Development Know Your Number®

A business development professional with 20 years of sales and marketing experience in the IT, health & fitness and insurance industries. Andy is a licensed life & health insurance producer, and most recently held executive business development roles at Pearl Insurance and The Kessler Group. He has a proven track record of creating national partnerships within the employer, association, non-profit and retail communities. Andy received his B.S. degree from the University of Massachusetts in Amherst.

Mark Ruby
 Senior Vice President, Corporate Business Development and Innovation

Mr. Ruby has been with BioSignia for eight years and has extensive sales and marketing expertise in the area of healthcare predictive modeling technologies and their use in employer wellness and medical management. He has over 25 years of experience in the healthcare industry and has held senior executive sales and marketing roles with both large and small healthcare companies. Mr. Ruby was formerly with Baxter Healthcare, a Fortune 500 healthcare company where he held several sales and marketing management positions of increasing responsibility.